Hepatitis B virus prevalence, risk factors and genotype distribution in HIV infected patients from West Java, Indonesia

Journal of Clinical Virology

Volumn 59, Issue 4, 2014, Pages 235-241

  Fibriani, Azzania ^a,b   Wisaksana, Rudi ^c   Alisjahbana, Bachti ^c   Indrati, Agnes ^c   Schutten, Martin ^a   van Crevel, Reinout ^d   van der Ven, Andre ^d   Boucher, Charles A B ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b BANDUNG INSTITUTE OF TECHNOLOGY   (Indonesia)

^c PADJADJARAN UNIVERSITY   (Indonesia)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

HBV; HIV; Indonesia

Indexed keywords

EFAVIRENZ; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; LOPINAVIR; NEVIRAPINE; RITONAVIR; STAVUDINE; TENOFOVIR; VIRUS DNA; VIRUS RNA; ZIDOVUDINE;

ADULT; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG USE; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INCIDENCE; INDONESIA; INFECTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PRIORITY JOURNAL; RISK FACTOR; TATTOOING;

HBV; HIV; INDONESIA;

ADULT; CROSS-SECTIONAL STUDIES; EPIDEMIOLOGIC STUDIES; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HIV INFECTIONS; HUMANS; INDONESIA; MALE; PREVALENCE; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84895920539     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2014.01.012     Document Type: Article

References (26)

1. Alter M.J. Epidemiology of viral hepatitis and HIV co-infection. J Hepatol 2006, 44(Suppl. 1):S6-S9.
2. Li Y.J., Wang H.L., Li T.S. Hepatitis B virus/human immunodeficiency virus coinfection: interaction among human immunodeficiency virus infection, chronic hepatitis B virus infection, and host immunity. Chin Med J (Engl) 2012, 125:2371-2377.
3. Thio C.L. Hepatitis B and human immunodeficiency virus coinfection. Hepatology 2009, 49(Suppl. 5):S138-S145.
4. Wang H., Li Y., Zhang C., Han Y., Zhang X., Zhu T., et al. Immunological and virological responses to cART in HIV/HBV co-infected patients from a multicenter cohort. AIDS 2012, 26:1755-1763.
5. Chadwick D., Ankcorn M., Sarfo F., Phillips R., Fox Z., Garcia A., et al. Outcomes of starting first-line antiretroviral therapy in hepatitis B virus/HIV-coinfected patients in Ghana. J Antimicrob Chemother 2012, 67:2939-2942.
6. Hoffmann C.J., Seaberg E.C., Young S., Witt M.D., D'Acunto K., Phair J., et al. Hepatitis B and long-term HIV outcomes in coinfected HAART recipients. AIDS 2009, 23:1881-1889.
7. Idoko J., Meloni S., Muazu M., Nimzing L., Badung B., Hawkins C., et al. Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria. Clin Infect Dis 2009, 49:1268-1273.
8. Anggorowati N., Yano Y., Heriyanto D.S., Rinonce H.T., Utsumi T., Mulya D.P., et al. Clinical and virological characteristics of hepatitis B or C virus co-infection with HIV in Indonesian patients. J Med Virol 2012, 84:857-865.
9. Sheng W.H., Chen M.Y., Hsieh S.M., Hsiao C.F., Wang J.T., Hung C.C., et al. Impact of chronic hepatitis B virus (HBV) infection on outcomes of patients infected with HIV in an area where HBV infection is hyperendemic. Clin Infect Dis 2004, 38:471-477.
10. UNAIDS UNAIDS Global Report 2010 2010.
11. Akbar N., Basuki B., Mulyanto Garabrant D.H., Sulaiman A., Noer H.M. Ethnicity, socioeconomic status, transfusions and risk of hepatitis B and hepatitis C infection. J Gastroenterol Hepatol 1997, 12:752-757.
12. Wisaksana R., Indrati A.K., Fibriani A., Rogayah E., Sudjana P., Djajakusumah T.S., et al. Response to first-line antiretroviral treatment among human immunodeficiency virus-infected patients with and without a history of injecting drug use in Indonesia. Addiction 2010, 105:1055-1061.
13. Alisjahbana B., Susanto H., Roesli R., Yusuf H., Hinduan Z., Mase J.C., et al. Prevention, control and treatment of HIV-AIDS among injecting drug use in Bandung, Indonesia. Acta Med Indonesia 2009, 41(Suppl. 1):65-69.
14. Pas S.D., Fries E., De Man R.A., Osterhaus A.D., Niesters H.G. Development of a quantitative real-time detection assay for hepatitis B virus DNA and comparison with two commercial assays. J Clin Microbiol 2000, 38:2897-2901.
15. Fibriani A., Farah N., Kusumadewi I., Pas S.D., van Crevel R., van der Ven A., et al. Low cost HIV-1 quantitative RT-PCR assay in resource-limited settings: improvement and implementation. J Virol Methods 2012, 185:118-123.
16. Nijhuis M., Boucher C.A., Schuurman R. Sensitive procedure for the amplification of HIV-1 RNA using a combined reverse-transcription and amplification reaction. Biotechniques 1995, 9:178-182.
17. Mulyanto Depamede S.N., Surayah K., Tsuda F., Ichiyama K., Takahashi M., Okamoto H.A. A nationwide molecular epidemiological study on hepatitis B virus in Indonesia: identification of two novel subgenotypes, B8 and C7. Arch Virol 2009, 154:1047-1059.
18. Utsumi T., Yano Y., Lusida M.I., Nasronudin Amin M., Juniastuti Soetjipto Hotta H., Hayashi Y. Detection of highly prevalent hepatitis B virus co-infection with HIV in Indonesia. Hepatol Res 2012, 43:1032-1039.
19. Geretti A.M., Patel M., Sarfo F.S., Chadwick D., Verheyen J., Fraune M., et al. Detection of highly prevalent hepatitis B virus coinfection among HIV-seropositive persons in Ghana. J Clin Microbiol 2010, 48:3223-3230.
20. Attia K.A., Eholie S., Messou E., Danel C., Polneau S., Chenal H., et al. Prevalence and virological profiles of hepatitis B infection in human immunodeficiency virus patients. World J Hepatol 2012, 4:218-223.
21. Nelwan E.J., Van Crevel R., Alisjahbana B., Indrati A.K., Dwiyana R.F., Nuralam N., et al. Human immunodeficiency virus, hepatitis B and hepatitis C in an Indonesian prison: prevalence, risk factors and implications of HIV screening. Trop Med Int Health 2010, 15:1491-1498.
22. Micalessi M.I., De Cock L., Vranckx R. Hepatitis B virus (HBV) genotyping in Belgian patients with chronic HBV infection. Clin Microbiol Infect 2005, 11:499-501.
23. Pourkarim M.R., Lemey P., Amini-Bavil-Olyaee S., Houspie L., Verbeeck J., Rahman M., et al. Molecular characterization of hepatitis B virus strains circulating in Belgian patients co-infected with HIV and HBV: overt and occult infection. J Med Virol 2011, 83:1876-1884.
24. Kramvis A., Kew M.C. Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes. Hepatol Res 2007, 37(s1):S9-S19.
25. Makondo E., Bell T.G., Kramvis A. Genotyping and molecular characterization of hepatitis B virus from human immunodeficiency virus-infected individuals in southern Africa. PLoS ONE 2012, 7:e46345.
26. WHO Antiretroviral therapy for HIV infection in adults and adolescents. Recommendations for a public health approach 2010 revision 2010.